Looking at the technical chart for ELV stock, in the past 10 weeks, the bulls have only succeeded in posting three ...

Q2 2025 Earnings Call Transcript July 17, 2025 Elevance Health Inc. misses on earnings expectations. Reported EPS is $8.84 ...

Elevance cut its annual profit forecast and missed Wall Street estimates for quarterly earnings on Thursday, the latest U.S.

What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the ...

Elevance Health reported $1.7 billion in profit during the second quarter, down 24% from Q2 2024, which was enough to drive ...

The Indianapolis company reduced its 2025 earnings target to $24.10 a share from a prior estimated range between $28.30 and $29 a share. On an adjusted basis, Elevance cut its projection to $30 a ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to $461.00 from $458.00. David Windley has given his Buy ...

Elevance has pushed deeper into home healthcare, mental-health services, and pharmacy benefits over the past few years, most recently buying up myNexus, a company that helps patients get medical ...

Mizuho Securities analyst Ann Hynes maintained a Buy rating on Elevance Health (ELV – Research Report) on June 17 and set a price target of $585.00. The company’s shares closed yesterday at ...

UPDATED: 1:30 p.m. on Jan. 23 | Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year over year.

For Immediate ReleaseChicago, IL – March 14, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Cencora, Inc. COR and ICON plc ICLR.